Clinical Trial Update: CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients

View source ↗

Summary

This clinical trial update describes evaluating CYP2D6 genotyping using the AmpliChip CYP450 assay to guide tamoxifen-treated breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Breast Cancer | Status: UNKNOWN